Cargando…

Melanoma cell migration is upregulated by tumour necrosis factor-α and suppressed by α-melanocyte-stimulating hormone

We reported recently that the inflammatory cytokine tumour necrosis factor α (TNF-α) can upregulate integrin expression, cell attachment and invasion of cells through fibronectin in a human melanoma cell line (HBL). Furthermore, the actions of TNF-α were suppressed by the addition of an anti-inflamm...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhu, N, Lalla, R, Eves, P, Brown, T L H, King, A, Kemp, E H, Haycock, J W, MacNeil, S
Formato:	Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2004
Materias:	Experimental Therapeutics
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2409669/ https://www.ncbi.nlm.nih.gov/pubmed/15054471 http://dx.doi.org/10.1038/sj.bjc.6601698

Ejemplares similares

Anti-inflammatory and anti-invasive effects of α-melanocyte-stimulating hormone in human melanoma cells
por: Eves, P, et al.
Publicado: (2003)

TNF-α increases human melanoma cell invasion and migration in vitro: the role of proteolytic enzymes
por: Katerinaki, E, et al.
Publicado: (2003)

Desacetyl-α-melanocyte stimulating hormone and α-melanocyte stimulating hormone are required to regulate energy balance
por: Mountjoy, Kathleen G., et al.
Publicado: (2017)

Alpha-melanocyte stimulating hormone (α-MSH): biology, clinical relevance and implication in melanoma
por: Dall’Olmo, Luigi, et al.
Publicado: (2023)

Inhibition of androstenediol-dependent LNCaP tumour growth by 17α-ethynyl-5α-androstane-3α, 17β-diol (HE3235)
por: Trauger, R, et al.
Publicado: (2009)

Macrophage migration inhibitory factor produced by the tumour stroma but not by tumour cells regulates angiogenesis in the B16-F10 melanoma model
por: Girard, E, et al.
Publicado: (2012)

Fenretinide-dependent upregulation of death receptors through ASK1 and p38α enhances death receptor ligand-induced cell death in Ewing's sarcoma family of tumours
por: White, D E, et al.
Publicado: (2010)

Expression level of integrin α5 on tumour cells affects the rate of metastasis to the kidney
por: Tani, N, et al.
Publicado: (2003)

Zonal image analysis of tumour vascular perfusion, hypoxia, and necrosis
por: Fenton, B M, et al.
Publicado: (2002)

Receptor-Mediated Melanoma Targeting with Radiolabeled α-Melanocyte-Stimulating Hormone: Relevance of the Net Charge of the Ligand
por: Bapst, Jean-Philippe, et al.
Publicado: (2017)

Preclinical Melanoma Imaging with (68)Ga-Labeled α-Melanocyte-Stimulating Hormone Derivatives Using PET
por: Zhang, Chengcheng, et al.
Publicado: (2017)

The anticancer drug mithramycin A sensitises tumour cells to apoptosis induced by tumour necrosis factor (TNF)
por: Duverger, V, et al.
Publicado: (2004)

Tumour growth and resistance to gemcitabine of pancreatic cancer cells are decreased by AP-2α overexpression
por: Jonckheere, N, et al.
Publicado: (2009)

Interplay between cadherins and α2β1 integrin differentially regulates melanoma cell invasion
por: Siret, Carole, et al.
Publicado: (2015)

Soluble tumour necrosis factor receptor type II and survival in colorectal cancer
por: Babic, Ana, et al.
Publicado: (2016)

Combination therapy with PEG-IFN-α and 5-FU inhibits HepG2 tumour cell growth in nude mice by apoptosis of p53
por: Hagiwara, S, et al.
Publicado: (2007)

Cathepsin-B and cathepsin-L expression levels do not correlate with sensitivity of tumour cells to TNF-α-mediated apoptosis
por: Gewies, A, et al.
Publicado: (2003)

Selective Cyclized α-Melanocyte-Stimulating Hormone Derivative with Multiple N-Methylations for Melanoma Imaging with Positron Emission Tomography
por: Zhang, Chengcheng, et al.
Publicado: (2020)

In vivo isolated kidney perfusion with tumour necrosis factor α (TNF-α) in tumour-bearing rats
por: Veen, A H van der, et al.
Publicado: (1999)

α-Melanocyte-stimulating-hormone (α-MSH) modulates human chondrocyte activation induced by proinflammatory cytokines
por: Capsoni, Franco, et al.
Publicado: (2015)

Tumour necrosis factor-α in nasal allergy
por: Hisamatsu, K., et al.
Publicado: (1995)

Pinostrobin Suppresses the α-Melanocyte-Stimulating Hormone-Induced Melanogenic Signaling Pathway
por: Athapaththu, Athapaththu Mudiyanselage Gihan Kavinda, et al.
Publicado: (2023)

Targeting SRPK1 to control VEGF-mediated tumour angiogenesis in metastatic melanoma
por: Gammons, M V, et al.
Publicado: (2014)

The effect of tumour necrosis factor-α (TNF-α) muteins on human neutrophils in vitro
por: Tchorzewski, H., et al.
Publicado: (1993)

Prostaglandin D(2) production in FM55 melanoma cells is regulated by α-melanocyte-stimulating hormone and is not related to melanin production
por: Masoodi, Mojgan, et al.
Publicado: (2010)

The α-melanocyte stimulating hormone/peroxisome proliferator activated receptor-γ pathway down-regulates proliferation in melanoma cell lines
por: Flori, Enrica, et al.
Publicado: (2017)

The pharmacological properties of 3-arm or 4-arm DOTA constructs for conjugation to α-melanocyte-stimulating hormone analogues for melanoma imaging
por: Kobayashi, Masato, et al.
Publicado: (2019)

(18)F-Labeled Cyclized α-Melanocyte-Stimulating Hormone Derivatives for Imaging Human Melanoma Xenograft with Positron Emission Tomography
por: Zhang, Chengcheng, et al.
Publicado: (2019)

Upregulation of cyclooxygenase-2 is accompanied by increased expression of nuclear factor-κB and IκB kinase-α in human colorectal cancer epithelial cells
por: Charalambous, M P, et al.
Publicado: (2003)

Immunofluorescent detection of hormone receptors in cutaneous melanocytic tumours.
por: Thompson, A. J., et al.
Publicado: (1981)

Selectively inhibiting malignant melanoma migration and invasion in an engineered skin model using actin-targeting dinuclear Ru(II)-complexes
por: Raza, Ahtasham, et al.
Publicado: (2022)

Optimising the combination dosing strategy of abemaciclib and vemurafenib in BRAF-mutated melanoma xenograft tumours
por: Tate, Sonya C, et al.
Publicado: (2016)

α‐Melanocyte‐stimulating hormone inhibition of oxytocin neurons switches to excitation in late pregnancy and lactation
por: Perkinson, Michael R., et al.
Publicado: (2022)

Potentiation of ionising radiation by targeting tumour necrosis factor alpha using a bispecific antibody in human pancreatic cancer
por: Azria, D, et al.
Publicado: (2003)

Human DESC1 serine protease confers tumorigenic properties to MDCK cells and it is upregulated in tumours of different origin
por: Viloria, C G, et al.
Publicado: (2007)

Elastin-derived peptides enhance melanoma growth in vivo by upregulating the activation of Mcol-A (MMP-1) collagenase
por: Devy, J, et al.
Publicado: (2010)

Camptothecin-Loaded Liposomes with α-Melanocyte-Stimulating Hormone Enhance Cytotoxicity Toward and Cellular Uptake by Melanomas: An Application of Nanomedicine on Natural Product
por: Lin, Chih-Hung, et al.
Publicado: (2013)

Dynamic changes of α-melanocyte-stimulating hormone levels in the serum of patients with craniocerebral trauma
por: Du, Xiaoguang, et al.
Publicado: (2017)

Antifibrotic and Anti-Inflammatory Actions of α-Melanocytic Hormone: New Roles for an Old Player
por: Dinparastisaleh, Roshan, et al.
Publicado: (2021)

Exogenous tumour necrosis factor α induces suppression of autoimmune arthritis
por: Kim, Eugene Y, et al.
Publicado: (2008)

Cannot write session to /tmp/vufind_sessions/sess_97mlr5mdb87mi2621jlnvs50b1